miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-22
DOI
10.1186/s13046-018-0906-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-203 Induces Apoptosis by TargetingBmi-1in YD-38 Oral Cancer Cells
- (2018) JAE-SUNG KIM et al. ANTICANCER RESEARCH
- MicroRNA-302c represses epithelial–mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer
- (2018) Wenqi Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2
- (2018) Peng Ma et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Sevoflurane suppresses proliferation by upregulating microRNA-203 in breast cancer cells
- (2018) Jiaying Liu et al. Molecular Medicine Reports
- Numb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling
- (2017) Federico Bocci et al. Journal of the Royal Society Interface
- MicroRNA-194 represses glioma cell epithelial-to-mesenchymal transition by targeting Bmi1
- (2017) Xi Zhang et al. ONCOLOGY REPORTS
- MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells
- (2017) Jun Lin et al. Experimental and Therapeutic Medicine
- miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer
- (2017) Yong Zhou et al. Scientific Reports
- MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM
- (2016) Ping Zhou et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC)
- (2016) Jennifer M. Scalici et al. CANCER
- MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway
- (2016) Zhao Xiaohong et al. TUMOR BIOLOGY
- miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer
- (2016) Shuqian He et al. OncoTargets and Therapy
- Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas
- (2016) Maria V. Bogachek et al. Stem Cell Reports
- MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2
- (2016) Biao Deng et al. Scientific Reports
- Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
- (2015) Ernest K. Amankwah et al. GENETIC EPIDEMIOLOGY
- miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer
- (2015) HONG TAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
- (2015) Xin Zhang et al. PLoS One
- CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling
- (2015) Lauren A. Baldwin et al. Oncotarget
- Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
- (2014) Michael R. Clemens et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
- (2014) Yan Sun et al. JOURNAL OF PATHOLOGY
- miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
- (2014) FEI GUO et al. ONCOLOGY REPORTS
- MicroRNA-7 Inhibits Tumor Metastasis and Reverses Epithelial-Mesenchymal Transition through AKT/ERK1/2 Inactivation by Targeting EGFR in Epithelial Ovarian Cancer
- (2014) Xingchen Zhou et al. PLoS One
- Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells
- (2014) Zixuan Chen et al. PLoS One
- The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer
- (2014) Masaaki Takai et al. Journal of Ovarian Research
- A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
- (2013) R. J. Kelly et al. ANNALS OF ONCOLOGY
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Saponins from the Roots ofPlatycodon grandiflorumSuppresses TGFβ1-Induced Epithelial-Mesenchymal Transition Via Repression of PI3K/Akt, ERK1/2 and Smad2/3 Pathway in Human Lung Carcinoma A549 Cells
- (2013) Jae Ho Choi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- miR-203 inhibits proliferation of HCC cells by targeting survivin
- (2012) Wang Wei et al. CELL BIOCHEMISTRY AND FUNCTION
- Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways
- (2012) Kentaro Nakayama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
- (2011) A. W. Tolcher et al. ANNALS OF ONCOLOGY
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture
- (2010) Jozien Helleman et al. GYNECOLOGIC ONCOLOGY
- Expression Profiles of Genes Involved in Poor Prognosis of Epithelial Ovarian Carcinoma
- (2010) Shozo Yoshida et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- X-linked Inhibitor of Apoptosis Protein and Its E3 Ligase Activity Promote Transforming Growth Factor-β-mediated Nuclear Factor-κB Activation during Breast Cancer Progression
- (2009) Jason R. Neil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More